Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deborah P Merke

Showing results (31-40 of 112) with videos related to

Pageof 12
Sort By:
Human Genetics|August 14, 2012
Complement component 4 copy number variation and CYP21A2 genotype associations in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiencyWuyan Chen, Zhi Xu, Miki Nishitani, et al.
The Journal of Clinical Endocrinology and Metabolism|March 28, 2018
Longitudinal Assessment of Illnesses, Stress Dosing, and Illness Sequelae in Patients With Congenital Adrenal HyperplasiaDiala El-Maouche, Courtney J Hargreaves, Ninet Sinaii, et al.
Journal of the Endocrine Society|January 15, 2021
11-Oxygenated Androgens Useful in the Setting of Discrepant Conventional Biomarkers in 21-Hydroxylase DeficiencySmita Jha, Adina F Turcu, Ninet Sinaii, et al.
The Journal of Clinical Endocrinology and Metabolism|October 10, 2018
Characterization of the CYP11A1 Nonsynonymous Variant p.E314K in Children Presenting With Adrenal InsufficiencyVipula Kolli, Hannah Kim, Ahmed Torky, et al.
The International Journal of Neuropsychopharmacology|September 24, 2010
Increased medial temporal lobe and striatal grey-matter volume in a rare disorder of androgen excess: a voxel-based morphometry (VBM) studySven C Mueller, Deborah P Merke, Ellen W Leschek, et al.
Molecular Genetics & Genomic Medicine|December 17, 2020
A TNXB splice donor site variant as a cause of hypermobility type Ehlers-Danlos syndrome in patients with congenital adrenal hyperplasiaQizong Lao, Ashwini Mallappa, Fabio Rueda Faucz, et al.
Frontiers in Endocrinology|June 10, 2026
Perceptions of CAH self-management and stress dosing in relation to health-related quality of life as measured by CAHQLMyrto Eleni Flokas, Sarah Kulkarni, Peyton Lee, et al.
The Journal of Clinical Endocrinology and Metabolism|March 7, 2021
Cardiovascular Disease Risk Factors and Metabolic Morbidity in a Longitudinal Study of Congenital Adrenal HyperplasiaAhmed Torky, Ninet Sinaii, Smita Jha, et al.
BMC Research Notes|November 1, 2019
Measurement of serum tenascin-X in patients with congenital adrenal hyperplasia at risk for Ehlers-Danlos contiguous gene deletion syndrome CAH-XVipula Kolli, Hannah Kim, Hamsini Rao, et al.
The Journal of Clinical Endocrinology and Metabolism|July 11, 2002
Flutamide decreases cortisol clearance in patients with congenital adrenal hyperplasiaEvangelia Charmandari, Karim A Calis, Margaret F Keil, et al.
Pageof 12

Showing results (31-40 of 112) with videos related to

Sort By:
Pageof 12
Human Genetics|August 14, 2012
Complement component 4 copy number variation and CYP21A2 genotype associations in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiencyWuyan Chen, Zhi Xu, Miki Nishitani, et al.
The Journal of Clinical Endocrinology and Metabolism|March 28, 2018
Longitudinal Assessment of Illnesses, Stress Dosing, and Illness Sequelae in Patients With Congenital Adrenal HyperplasiaDiala El-Maouche, Courtney J Hargreaves, Ninet Sinaii, et al.
Journal of the Endocrine Society|January 15, 2021
11-Oxygenated Androgens Useful in the Setting of Discrepant Conventional Biomarkers in 21-Hydroxylase DeficiencySmita Jha, Adina F Turcu, Ninet Sinaii, et al.
The Journal of Clinical Endocrinology and Metabolism|October 10, 2018
Characterization of the CYP11A1 Nonsynonymous Variant p.E314K in Children Presenting With Adrenal InsufficiencyVipula Kolli, Hannah Kim, Ahmed Torky, et al.
The International Journal of Neuropsychopharmacology|September 24, 2010
Increased medial temporal lobe and striatal grey-matter volume in a rare disorder of androgen excess: a voxel-based morphometry (VBM) studySven C Mueller, Deborah P Merke, Ellen W Leschek, et al.
Molecular Genetics & Genomic Medicine|December 17, 2020
A TNXB splice donor site variant as a cause of hypermobility type Ehlers-Danlos syndrome in patients with congenital adrenal hyperplasiaQizong Lao, Ashwini Mallappa, Fabio Rueda Faucz, et al.
Frontiers in Endocrinology|June 10, 2026
Perceptions of CAH self-management and stress dosing in relation to health-related quality of life as measured by CAHQLMyrto Eleni Flokas, Sarah Kulkarni, Peyton Lee, et al.
The Journal of Clinical Endocrinology and Metabolism|March 7, 2021
Cardiovascular Disease Risk Factors and Metabolic Morbidity in a Longitudinal Study of Congenital Adrenal HyperplasiaAhmed Torky, Ninet Sinaii, Smita Jha, et al.
BMC Research Notes|November 1, 2019
Measurement of serum tenascin-X in patients with congenital adrenal hyperplasia at risk for Ehlers-Danlos contiguous gene deletion syndrome CAH-XVipula Kolli, Hannah Kim, Hamsini Rao, et al.
The Journal of Clinical Endocrinology and Metabolism|July 11, 2002
Flutamide decreases cortisol clearance in patients with congenital adrenal hyperplasiaEvangelia Charmandari, Karim A Calis, Margaret F Keil, et al.
Pageof 12